{"database": "openregs", "table": "federal_register", "rows": [["2026-09808", "Government Owned Inventions Available for License: Synergistic Interactions for Improved Cancer Treatment", "Notice", "The National Cancer Institute (NCI) seeks research co- development partners and/or licensees to develop hetIL-15 in combination with other agents, such as PPARa agonists (Fenofibrate), FLT3 inhibitors (quizartinib), IL-12, or chemotherapy into a therapeutic for cancer.", "2026-05-15", 2026, 5, "https://www.federalregister.gov/documents/2026/05/15/2026-09808/government-owned-inventions-available-for-license-synergistic-interactions-for-improved-cancer", "https://www.govinfo.gov/content/pkg/FR-2026-05-15/pdf/2026-09808.pdf", "Health and Human Services Department; National Institutes of Health", "221,353", "The National Cancer Institute (NCI) seeks research co- development partners and/or licensees to develop hetIL-15 in combination with other agents, such as PPARa agonists (Fenofibrate), FLT3 inhibitors (quizartinib), IL-12, or chemotherapy into a...", null]], "columns": ["document_number", "title", "type", "abstract", "publication_date", "pub_year", "pub_month", "html_url", "pdf_url", "agency_names", "agency_ids", "excerpts", "regulation_id_numbers"], "primary_keys": ["document_number"], "primary_key_values": ["2026-09808"], "units": {}, "query_ms": 0.5095480009913445, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}